Andrew Hedin joined Bessemer in 2015 as a Senior Associate in the Cambridge office, where he focuses on investments in healthcare.
Prior to Bessemer, Andrew worked at Fidelity Biosciences, Fidelity's healthcare-focused venture capital fund that spans the US, EU, China and India. While there, he invested broadly across healthcare in early stage healthcare IT, healthcare services, biotech and medtech startups. Andrew has also worked with Health Essentials, a healthcare services company focused on providing post-acute and coordinated care to the frail elderly. Andrew began his career at Leerink Partners, where he was an Associate in the strategy consulting division of the boutique healthcare-focused firm. At Leerink, Andrew focused on growth strategies for pharmaceutical, biotech and medical device companies.
Andrew holds an MBA with honors from The Wharton School, where he majored in Health Care Management and Finance, as well as a B.A. in Biological Basis of Behavior from the University of Pennsylvania, where he conducted research in both the neuroscience and psychology departments. Andrew co-chaired Wharton's Health Care Conference and also led a Startup Weekend focused on healthcare tech companies in Philadelphia.